METHOD FOR OPTIMISING IMANITIB THERAPY OF PROLIFERATIVE DISEASES MEDIATED BY THYROSINE KINASE KIT RECEPTOR Russian patent published in 2014 - IPC A61K31/506 

Abstract RU 2537223 C2

FIELD: medicine.

SUBSTANCE: invention discloses a method of treating proliferative diseases mediated by KIT receptor, in greater detail the invention discloses a method of treating stromal gastrointestinal tumours (SGITs) in individuals, involving the stages: administering the pre-set fixed amount of 200 to 800 mg of imanitib mesylate as a daily dose into a human patient being in need thereof as suffering a SGIT diseases, taking at least one blood sample from the above patient for the first 12 months of the therapy, determining the least plasma imanitib concentration (Cmin) and selecting a dose of imanitib or its pharmaceutically acceptable salt so that to achieve Cmin falling within the range of 1100 to 2500 ng/ml of imanitib mesylate in the above patient.

EFFECT: invention is effective in treating the stromal gastrointestinal tumours in individuals.

5 cl, 1 dwg, 1 ex

Similar patents RU2537223C2

Title Year Author Number
ADMINISTRATION OF MIDOSTAURIN FOR TREATING GASTROINTESTINAL STROMAL TUMOURS 2005
  • Kols Jan
RU2410098C2
METHOD OF OPTIMISING THERAPY OF PHILADELPHIA CHROMOSOME POSITIVE LEUKAEMIA BY Ab1-TYROSINE KINASE INHIBITORS 2007
  • Gatmann Inza
  • Maon Fransua-Av'Er
  • Molimar Mat'E
  • Pikar Stefan
  • Van Jan'Fehn
RU2483732C2
INHIBITORS OF MUTANT FORM OF KINASE KIT 2004
  • Bukhdunger Ehlizabet
  • Fabbro Doriano
RU2362562C2
INHIBITORS OF KIT KINASE MUTANT FORM 2004
  • Bukhdunger Ehlizabet
  • Fabbro Doriano
RU2405553C1
TYROSINE KINASE INHIBITOR OR ITS PHARMACEUTICAL SALT FOR TREATMENT OF SYSTEMIC MASTOCYTOSIS 2016
  • Moussy, Alain
  • Kinet, Jean-Pierre
RU2778337C2
COMPOSITIONS FOR TREATING SYSTEMIC MASTOCYTOSIS 2006
  • Falent Peter
RU2429848C2
COMPOSITIONS AND METHODS OF TREATING KIT- AND PDGFRα-MEDIATED DISEASES 2020
  • Kim, Dzhozef, L.
  • Dajnin, Tomas, A.
  • Guzi, Timoti
RU2817354C2
USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR TREATING SYSTEMIC MASTOCYTOSIS 2006
  • Olland Lejla
  • Fabbro Doriano
  • Mestan Jurgen
  • Manli Pol U.
RU2445960C2
USING DERIVATIVES OF N-PHENYL-2-PYRIMIDINEAMINE AGAINST MASTOCYTE-BASE DISEASES SIMILAR TO ALLERGIC DISTURBANCE 2002
  • Koike Kenichi
  • Komijama Atsushi
  • Takeuchi Kouichi
  • Khajnrikh Majkl
  • Nakadzhima Motovo
RU2304436C2
METHOD FOR TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY ACTIVITY OF KINASE BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R 2010
  • Nil Gallager
  • Ofeliya In
RU2625835C2

RU 2 537 223 C2

Authors

Jan'Fehn Van

Ehlizabet Verle

Dates

2014-12-27Published

2009-01-21Filed